Month: July 2011
Arun Menawat Discusses Novadaq Technologies, a Surgical Imaging Company
Novadaq Technologies (TSX:NDQ) President & CEO Arun Menawat, Ph.D was interviewed by OneMedRadio and discusses the roll out of his surgical imaging technology.
Jason Napodano Discusses ISCO’s Stem Cell Development and Recent Research Report
Zack’s Investment Research’s Senior Biotech Analyst, Jason Napodano, was interviewed by OneMedRadio where he discussed International Stem Cell Corp [OTC:ISCO].
OneMedPlace Launches OneMedRadio to Expand Coverage of Public Companies
OneMedPlace (OMP) announced the creation of OneMedRadio to anchor an expansion of coverage on small public companies in the healthcare and life sciences sector.
Bio-Rad receives pre-market approval for HIV test from FDA
Bio-Rad Laboratories (NYSE:BIO) announced Monday it received FDA premarket approval for its fourth generation human immunodeficiency virus (HIV) diagnostic test.
Drug maker GlaxoSmithKline receives upbeat results in Promacta phase three study
Biotech company Ligand Pharmaceuticals Inc. reported Tuesday that its partner GlaxoSmithKline received encouraging results in Hepatitis C study.
E-Therapeutics expects to generate a “wealth of data” from clinical trials
E-Therapeutics (LON:ETX) expects to generate a “wealth of data” from a clinical programme focusing on four drug candidates.
Roka Bioscience Raises $20 Million
Roka Bioscience revealed that it has completed a Series C round of equity financing, raising $20M.
FDA Needs To Replace Flawed 510(k) Medical Device Clearance Process
According to a report released by the Institute of Medicine (IOM) Friday, the U.S. Food and Drug Administration needs to develop a new regulatory framework to replace the 35-year-old 510(k) clearance process for medical devices.
Editor’s Note August 2, 2011
With this issue of the newly formatted Sentinel we are introducing OneMedRadio a product designed to bring our readers interviews with the CEOs and investors […]